Literature DB >> 36149528

Ketogenic state improves testosterone serum levels-results from a systematic review and meta-analysis.

Chiara Furini1,2, Giorgia Spaggiari2, Manuela Simoni1,2, Carla Greco3,4, Daniele Santi1,2.   

Abstract

BACKGROUND: It is widely demonstrated that obesity and hypogonadism are bi-directionally correlated, since the hypogonadism prevalence is higher in obese population, while weight loss increases testosterone serum levels. Several approaches are available to contrast weight excess, from simple dietary regimens to more complex surgical procedures. Ketogenic diets (KD) fit in this context and their application is growing year after year, aiming to improve the metabolic and weight patterns in obese patients. However, KD influence on testosterone levels is still poorly investigated.
OBJECTIVES: To systematically evaluate the potential effect of KD on testosterone levels.
METHODS: A systematic literature search was performed until April 2022 including studies investigating testosterone levels before and after KD. Secondary endpoints were body weight, estradiol and sex-hormone binding globulin serum levels. Any kind of KD was considered eligible, and no specific criteria for study populations were provided.
RESULTS: Seven studies (including eight trials) were included in the analysis for a total of 230 patients, five using normocaloric KD and three very low calories KD (VLCKD). Only three studies enrolled overweight/obese men. A significant total testosterone increase was recorded after any kind of KD considering 111 patients (2.86 [0.95, 4.77], p = 0.003). This increase was more evident considering VLCKD compared to normocaloric KD (6.75 [3.31, 10.20], p < 0.001, versus 0.98 [0.08, 1.88], p = 0.030). Meta-regression analyses highlighted significant correlations between the post-KD testosterone raise with patients' age (R-squared 36.4, p < 0.001) and weight loss (R-squared 73.6, p < 0.001).
CONCLUSIONS: Comprehensively, KD improved testosterone levels depending on both patients' age and KD-induced weight loss. However, the lack of information in included studies on hormones of the hypothalamic-pituitary-gonadal axis prevents an exhaustive comprehension about mechanisms connecting ketosis and testosterone homeostasis.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Androgens; Ketogenic diet; Testosterone; VLCKD

Year:  2022        PMID: 36149528     DOI: 10.1007/s12020-022-03195-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  44 in total

Review 1.  Metabolic Syndrome in Male Hypogonadism.

Authors:  Giulia Rastrelli; Sandra Filippi; Alessandra Sforza; Mario Maggi; Giovanni Corona
Journal:  Front Horm Res       Date:  2018-05-24       Impact factor: 2.606

2.  Prevalence of testosterone deficiency among aging men with and without morbidities.

Authors:  Juris Erenpreiss; Violeta Fodina; Rita Pozarska; Ksenija Zubkova; Alesja Dudorova; Anatolijs Pozarskis
Journal:  Aging Male       Date:  2019-06-01       Impact factor: 5.892

3.  Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.

Authors:  Shalender Bhasin; Juan P Brito; Glenn R Cunningham; Frances J Hayes; Howard N Hodis; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Frederick C Wu; Maria A Yialamas
Journal:  J Clin Endocrinol Metab       Date:  2018-05-01       Impact factor: 5.958

4.  Hypogonadism in men: Updates and treatments.

Authors:  Gina Ugo-Neff; Denise Rizzolo
Journal:  JAAPA       Date:  2022-05-01

Review 5.  Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis.

Authors:  Giovanni Corona; Giulia Rastrelli; Matteo Monami; Farid Saad; Michaela Luconi; Marcello Lucchese; Enrico Facchiano; Alessandra Sforza; Gianni Forti; Edoardo Mannucci; Mario Maggi
Journal:  Eur J Endocrinol       Date:  2013-05-02       Impact factor: 6.664

6.  Testosterone therapy: where do the latest guidelines agree and differ?

Authors:  Daniel L Pelzman; Kathleen Hwang
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2020-12       Impact factor: 3.243

Review 7.  Hypothalamic mechanisms of obesity-associated disturbance of hypothalamic-pituitary-ovarian axis.

Authors:  Xiaolin Chen; Zhuoni Xiao; Yuli Cai; Lili Huang; Chen Chen
Journal:  Trends Endocrinol Metab       Date:  2022-01-18       Impact factor: 10.586

Review 8.  Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis.

Authors:  L T van Hulsteijn; R Pasquali; F Casanueva; M Haluzik; S Ledoux; M P Monteiro; J Salvador; F Santini; H Toplak; O M Dekkers
Journal:  Eur J Endocrinol       Date:  2020-01       Impact factor: 6.664

Review 9.  Treatment of Functional Hypogonadism Besides Pharmacological Substitution.

Authors:  Giovanni Corona; Giulia Rastrelli; Annamaria Morelli; Erica Sarchielli; Sarah Cipriani; Linda Vignozzi; Mario Maggi
Journal:  World J Mens Health       Date:  2019-08-29       Impact factor: 5.400

Review 10.  Research Progress on the Relationship between Obesity-Inflammation-Aromatase Axis and Male Infertility.

Authors:  Liu Yuxin; Lin Chen; Luo Xiaoxia; Luo Yue; Lai Junjie; Li Youzhu; Zhou Huiliang; Liu Qicai
Journal:  Oxid Med Cell Longev       Date:  2021-02-08       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.